-
2026-06-24
GenSci's Triptorelin Acetate for Injection (II) Secures NMPA Approval for Central Precocious PubertyLearn More
-
2026-06-04
GenSci: Two Innovations Granted IND Clearance by FDALearn More
-
2026-05-28
Dr. Lei Jin of GenSci Shines at J.P. Morgan Global China Summit, Sharing Insights on Innovation and GlobalizationLearn More
-
2026-05-19
GenSci's Innovative IL-1α/β Bispecific Antibody Receives First FDA Clinical ApprovalLearn More
-
2026-05-15
GenSciP166 Selected as Late-Breaking Abstract at SID 2026Learn More
-
2025-10-13
GenSci Advances Women's Health with the Approval of Two Key ProductsLearn More
-
2025-10-09
From Long-acting Growth Hormone to Medical Devices: GenPEG Advances its High-purity ExpertiseLearn More
-
2025-09-18
GenSci Partners with Allergy Immunotherapy Leader ALK to Bring Innovative AIT Solutions for Chinese PatientsLearn More
-
2025-07-14
First Prescription for Firsekibart Issued in China for GALearn More
-
2025-07-04
Firsekibart Approved with 87% Reduction in Gout Recurrence Over 6 MonthsLearn More
-
2025-06-18
Gensci Showcases Women's Health and Immunology Innovations at BIO 2025Learn More